Disculpa, pero esta entrada está disponible sólo en English.
(English) FDA Approves Oral Treatment for Spinal Muscular Atrophy
(English)
SILVER SPRING, Md., Aug. 7, 2020 /PRNewswire/ — The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease…
